IFC Midnight picks up U.S. rights to Brandon Cronenberg’s Antiviral
The deal follows Cronenberg's debut feature bowing in Cannes in the Un Certain Regard section.
TF1 International has sold the U.S. releasing rights to writer/director Brandon Cronenberg‘s Antiviral (pictured) to IFC Midnight, on the heels of the Canadian film’s Cannes world premiere.
Cronenberg’s debut feature screened in the Un Certain Regard section in Cannes, and follows Syd March, an employee at a clinic that sells injections of live viruses harvested from sick celebrities to rabid fans.
“The film manages to skewer our culture’s obsession with celebrity while also delivering more than a fair share of chills and gruesome body horror. We look forward to working with Brandon and his team,” Jonathan Sehring, president of Sundance Selects/IFC Films, said on news of the U.S. acquisition deal.
The deal for the film was negotiated by Arianna Bocco, senior vice president of acquisitions and productions for Sundance Selects/IFC Films and Gregory Chambet of TF1 International acting for the filmmakers.
Antiviral will be released in Canada by Alliance Films.